Evidence map›Paper›PMID 28630863›Full record

Trial reportBioMed research international2017

The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment.

Cezary Chojnacki, Aleksandra Błońska, Jan Chojnacki

Full text readClinical Trial
In one paragraph

Trial report in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Effects ofJournal of experimental pharmacology · 2025
    Article
  5. Review
  6. Hepatic Encephalopathy and Melatonin.Antioxidants (Basel, Switzerland) · 2022
    Review
  7. Article
  8. Melatonin effect on platelet count in patients with liver disease.Gastroenterology and hepatology from bed to bench · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Possible application of melatonin treatment in human diseases of the biliary tract.American journal of physiology. Gastrointestinal and liver physiology · 2019
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cezary ChojnackiDepartment of Clinical Nutrition and Gastroenterological Diagnostics, Medical University, Lodz, Poland.
Aleksandra BłońskaDepartment of Clinical Nutrition and Gastroenterological Diagnostics, Medical University, Lodz, Poland.
Jan ChojnackiDepartment of Gastroenterology, Medical University, Lodz, Poland.ORCID 0000-0001-8766-7868

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Taking statins can cause increase in the level of aspartate and alanine aminotransferase. The aim of this study was to assess the usefulness of melatonin in counteracting the adverse hepatic events from statins.

Indexed as

HyperlipidemiasAgedAlanine TransaminaseAspartate AminotransferasesFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLiverMaleMelatoninMiddle AgedAlanine TransaminaseAspartate AminotransferasesHydroxymethylglutaryl-CoA Reductase InhibitorsMelatonin

Identifiers

PMID28630863
PMCPMC5467275

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.